These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3025927)

  • 21. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
    Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
    Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ACTH-like neuropeptides on animal behavior and man.
    Bohus B
    Pharmacology; 1979; 18(3):113-22. PubMed ID: 221943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of adrenocorticotrophic hormone (4-9) analog ORG 2766 in autistic children: effects on the organization of behavior.
    Buitelaar JK; van Engeland H; de Kogel KH; de Vries H; van Hooff JA; van Ree JM
    Biol Psychiatry; 1992 Jun; 31(11):1119-29. PubMed ID: 1326339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of ACTH-related peptides on acquisition of shuttle-box avoidance behavior of hypophysectomized rats.
    Fekete M; Bohus B; de Wied D
    Neuroendocrinology; 1983 Feb; 36(2):112-8. PubMed ID: 6300716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ACTH(4-9) analog ORG 2766 and recovery after brain damage in animal models--a review.
    van Rijzingen IM; Gispen WH; Spruijt BM
    Behav Brain Res; 1996 Jan; 74(1-2):1-15. PubMed ID: 8851911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study.
    Görtelmeyer R; Erbler H
    Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral effects of a synthetic corticotropin 4-9 analog in patients with depression and patients with Alzheimer's disease.
    Heuser I; Heuser-Link M; Gotthardt U; Grasser A; Holsboer F
    J Clin Psychopharmacol; 1993 Jun; 13(3):171-4. PubMed ID: 8394847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4-9 analogue ORG 2766 in IDDM patients with neuropathy.
    Bravenboer B; Hendrikse PH; Oey PL; van Huffelen AC; Groenhout C; Gispen WH; Erkelens DW
    Diabetologia; 1994 Apr; 37(4):408-13. PubMed ID: 8063043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of the adrenocorticotropin-(4-9) analogue, ORG 2766, and of dizolcipine (MK-801) on infarct volume in rat brain.
    Herz RC; Kasbergen CM; Versteeg DH; De Wildt DJ
    Eur J Pharmacol; 1998 Apr; 346(2-3):159-65. PubMed ID: 9652355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procedures in evaluating dementia--a study of conjoint application of two rating scales (SCAG and BCRS) and psychometric tests.
    Lolk A; Nielsen H; Kragh-Sørensen P
    Acta Psychiatr Scand; 1988 Nov; 78(5):592-8. PubMed ID: 3232537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of adrenocorticotropic hormone (ACTH4-10) on information network of the cardiovascular systems].
    Dmitrieva NV; Lonskaia LF; Bakaneva VF
    Vestn Ross Akad Med Nauk; 2010; (3):21-4. PubMed ID: 20420211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The MSH/ACTH analog ORG 2766 in anxiety disorders.
    Den Boer JA; Westenberg HG; De Vries H
    Peptides; 1992; 13(1):109-12. PubMed ID: 1320259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of an ACTH(4-9) analogue on cisplatin neuropathy of longstanding duration: a phase II study.
    Hilkens PH; van der Burg ME; Moll JW; van den Bent MJ; van Putten WL; Vecht CJ
    Clin Neurol Neurosurg; 1995 May; 97(2):139-41. PubMed ID: 7656487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer.
    van der Hoop RG; Vecht CJ; van der Burg ME; Elderson A; Boogerd W; Heimans JJ; Vries EP; van Houwelingen JC; Jennekens FG; Gispen WH
    N Engl J Med; 1990 Jan; 322(2):89-94. PubMed ID: 2152972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral 2-deoxyglucose accumulation in mice following chronic treatment with an ACTH4-9 analog, ORG 2766.
    Dunn AJ; Hurd RW
    Brain Res Bull; 1984 Apr; 12(4):369-71. PubMed ID: 6329482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postnatal treatment with ACTH-(4-9) analog ORG 2766 attenuates N-methyl-D-aspartate-induced excitotoxicity in rat nucleus basalis in adulthood.
    Horvath KM; Abrahám IM; Harkany T; Meerlo P; Bohus BG; Nyakas C; Luiten PG
    Eur J Pharmacol; 2000 Sep; 405(1-3):33-42. PubMed ID: 11033312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dose-response analysis of the beneficial effects of the ACTH-(4-9) analogue, Org 2766, on behavioural recovery following unilateral labyrinthectomy in guinea-pig.
    Gilchrist DP; Darlington CL; Smith PF
    Br J Pharmacol; 1994 Jan; 111(1):358-63. PubMed ID: 8012719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer.
    Roberts JA; Jenison EL; Kim K; Clarke-Pearson D; Langleben A
    Gynecol Oncol; 1997 Nov; 67(2):172-7. PubMed ID: 9367703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACTH/MSH like peptides in the treatment of cisplatin neuropathy.
    Gispen WH; Hamers FP; Vecht CJ; Jennekens FG; Neyt JP
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):179-83. PubMed ID: 1326318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High performance liquid chromatography of pharmacologically active amines and peptides in biological materials.
    Davis TP; Schoemaker H; Chen A; Yamamura HI
    Life Sci; 1982 Mar; 30(12):971-87. PubMed ID: 6280002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.